nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP3A4—Thiotepa—sarcoma	0.108	0.404	CbGbCtD
Tolterodine—CYP3A4—Mitoxantrone—sarcoma	0.0465	0.174	CbGbCtD
Tolterodine—CYP3A4—Vincristine—sarcoma	0.032	0.12	CbGbCtD
Tolterodine—CYP2D6—Doxorubicin—sarcoma	0.0314	0.118	CbGbCtD
Tolterodine—CYP3A4—Etoposide—sarcoma	0.0293	0.11	CbGbCtD
Tolterodine—Memory impairment—Thiotepa—sarcoma	0.0206	0.0281	CcSEcCtD
Tolterodine—CYP3A4—Doxorubicin—sarcoma	0.02	0.0748	CbGbCtD
Tolterodine—Urinary retention—Thiotepa—sarcoma	0.0112	0.0152	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.0105	0.0143	CcSEcCtD
Tolterodine—Urinary retention—Vincristine—sarcoma	0.00989	0.0135	CcSEcCtD
Tolterodine—Dysuria—Thiotepa—sarcoma	0.00948	0.0129	CcSEcCtD
Tolterodine—Weight increased—Thiotepa—sarcoma	0.00923	0.0126	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Etoposide—sarcoma	0.00871	0.0119	CcSEcCtD
Tolterodine—Dysuria—Vincristine—sarcoma	0.00841	0.0115	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00814	0.0111	CcSEcCtD
Tolterodine—Hallucination—Thiotepa—sarcoma	0.00808	0.011	CcSEcCtD
Tolterodine—Weight increased—Mitoxantrone—sarcoma	0.00797	0.0109	CcSEcCtD
Tolterodine—Urinary tract infection—Mitoxantrone—sarcoma	0.00759	0.0104	CcSEcCtD
Tolterodine—Flushing—Dactinomycin—sarcoma	0.00748	0.0102	CcSEcCtD
Tolterodine—Sinusitis—Mitoxantrone—sarcoma	0.00733	0.01	CcSEcCtD
Tolterodine—Hallucination—Vincristine—sarcoma	0.00716	0.00977	CcSEcCtD
Tolterodine—Influenza like illness—Epirubicin—sarcoma	0.00632	0.00863	CcSEcCtD
Tolterodine—Arthralgia—Thiotepa—sarcoma	0.00602	0.00821	CcSEcCtD
Tolterodine—Dry eye—Epirubicin—sarcoma	0.00601	0.0082	CcSEcCtD
Tolterodine—Anxiety—Thiotepa—sarcoma	0.00599	0.00818	CcSEcCtD
Tolterodine—Influenza like illness—Doxorubicin—sarcoma	0.00585	0.00798	CcSEcCtD
Tolterodine—Confusional state—Thiotepa—sarcoma	0.00581	0.00794	CcSEcCtD
Tolterodine—Infection—Thiotepa—sarcoma	0.00573	0.00782	CcSEcCtD
Tolterodine—Oedema—Dactinomycin—sarcoma	0.00572	0.00781	CcSEcCtD
Tolterodine—Infection—Dactinomycin—sarcoma	0.00569	0.00776	CcSEcCtD
Tolterodine—Abnormal vision—Epirubicin—sarcoma	0.00568	0.00775	CcSEcCtD
Tolterodine—Vertigo—Vincristine—sarcoma	0.00563	0.00768	CcSEcCtD
Tolterodine—Tachycardia—Thiotepa—sarcoma	0.00563	0.00768	CcSEcCtD
Tolterodine—Dry eye—Doxorubicin—sarcoma	0.00556	0.00759	CcSEcCtD
Tolterodine—Flushing—Etoposide—sarcoma	0.00541	0.00739	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00525	0.00717	CcSEcCtD
Tolterodine—Abnormal vision—Doxorubicin—sarcoma	0.00525	0.00717	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00521	0.00712	CcSEcCtD
Tolterodine—Chest pain—Mitoxantrone—sarcoma	0.00519	0.00709	CcSEcCtD
Tolterodine—Arthralgia—Mitoxantrone—sarcoma	0.00519	0.00709	CcSEcCtD
Tolterodine—Anxiety—Mitoxantrone—sarcoma	0.00518	0.00707	CcSEcCtD
Tolterodine—Somnolence—Thiotepa—sarcoma	0.00513	0.007	CcSEcCtD
Tolterodine—Oedema—Vincristine—sarcoma	0.00511	0.00698	CcSEcCtD
Tolterodine—Anaphylactic shock—Vincristine—sarcoma	0.00511	0.00698	CcSEcCtD
Tolterodine—Infection—Vincristine—sarcoma	0.00508	0.00693	CcSEcCtD
Tolterodine—Dyspepsia—Thiotepa—sarcoma	0.00508	0.00693	CcSEcCtD
Tolterodine—Confusional state—Mitoxantrone—sarcoma	0.00502	0.00685	CcSEcCtD
Tolterodine—Oedema—Mitoxantrone—sarcoma	0.00498	0.0068	CcSEcCtD
Tolterodine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00498	0.0068	CcSEcCtD
Tolterodine—Fatigue—Thiotepa—sarcoma	0.00497	0.00679	CcSEcCtD
Tolterodine—Infection—Mitoxantrone—sarcoma	0.00495	0.00675	CcSEcCtD
Tolterodine—Fatigue—Dactinomycin—sarcoma	0.00493	0.00673	CcSEcCtD
Tolterodine—Pain—Thiotepa—sarcoma	0.00493	0.00673	CcSEcCtD
Tolterodine—Constipation—Thiotepa—sarcoma	0.00493	0.00673	CcSEcCtD
Tolterodine—Pain—Dactinomycin—sarcoma	0.00489	0.00668	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00488	0.00666	CcSEcCtD
Tolterodine—Tachycardia—Mitoxantrone—sarcoma	0.00486	0.00663	CcSEcCtD
Tolterodine—Feeling abnormal—Thiotepa—sarcoma	0.00475	0.00649	CcSEcCtD
Tolterodine—Feeling abnormal—Dactinomycin—sarcoma	0.00472	0.00644	CcSEcCtD
Tolterodine—Gastrointestinal pain—Thiotepa—sarcoma	0.00472	0.00644	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00468	0.00639	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00466	0.00636	CcSEcCtD
Tolterodine—Vertigo—Etoposide—sarcoma	0.00456	0.00622	CcSEcCtD
Tolterodine—Abdominal pain—Thiotepa—sarcoma	0.00456	0.00622	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00454	0.00619	CcSEcCtD
Tolterodine—Abdominal pain—Dactinomycin—sarcoma	0.00452	0.00618	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00452	0.00616	CcSEcCtD
Tolterodine—Somnolence—Mitoxantrone—sarcoma	0.00443	0.00604	CcSEcCtD
Tolterodine—Fatigue—Vincristine—sarcoma	0.00441	0.00602	CcSEcCtD
Tolterodine—Dyspepsia—Mitoxantrone—sarcoma	0.00438	0.00598	CcSEcCtD
Tolterodine—Pain—Vincristine—sarcoma	0.00437	0.00597	CcSEcCtD
Tolterodine—Constipation—Vincristine—sarcoma	0.00437	0.00597	CcSEcCtD
Tolterodine—Dry skin—Epirubicin—sarcoma	0.00433	0.00591	CcSEcCtD
Tolterodine—Chest pain—Etoposide—sarcoma	0.00432	0.0059	CcSEcCtD
Tolterodine—Fatigue—Mitoxantrone—sarcoma	0.00429	0.00586	CcSEcCtD
Tolterodine—Pain—Mitoxantrone—sarcoma	0.00426	0.00581	CcSEcCtD
Tolterodine—Constipation—Mitoxantrone—sarcoma	0.00426	0.00581	CcSEcCtD
Tolterodine—Hypersensitivity—Thiotepa—sarcoma	0.00425	0.0058	CcSEcCtD
Tolterodine—Hypersensitivity—Dactinomycin—sarcoma	0.00422	0.00576	CcSEcCtD
Tolterodine—Gastrointestinal pain—Vincristine—sarcoma	0.00418	0.00571	CcSEcCtD
Tolterodine—Confusional state—Etoposide—sarcoma	0.00418	0.0057	CcSEcCtD
Tolterodine—Anaphylactic shock—Etoposide—sarcoma	0.00414	0.00565	CcSEcCtD
Tolterodine—Asthenia—Thiotepa—sarcoma	0.00414	0.00565	CcSEcCtD
Tolterodine—Infection—Etoposide—sarcoma	0.00412	0.00562	CcSEcCtD
Tolterodine—Asthenia—Dactinomycin—sarcoma	0.00411	0.0056	CcSEcCtD
Tolterodine—Feeling abnormal—Mitoxantrone—sarcoma	0.0041	0.0056	CcSEcCtD
Tolterodine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00407	0.00556	CcSEcCtD
Tolterodine—Tachycardia—Etoposide—sarcoma	0.00404	0.00552	CcSEcCtD
Tolterodine—Abdominal pain—Vincristine—sarcoma	0.00404	0.00552	CcSEcCtD
Tolterodine—Dry skin—Doxorubicin—sarcoma	0.00401	0.00547	CcSEcCtD
Tolterodine—Diarrhoea—Thiotepa—sarcoma	0.00395	0.00539	CcSEcCtD
Tolterodine—Abdominal pain—Mitoxantrone—sarcoma	0.00394	0.00537	CcSEcCtD
Tolterodine—Bronchitis—Epirubicin—sarcoma	0.00393	0.00536	CcSEcCtD
Tolterodine—Diarrhoea—Dactinomycin—sarcoma	0.00392	0.00534	CcSEcCtD
Tolterodine—Dysuria—Epirubicin—sarcoma	0.00382	0.00521	CcSEcCtD
Tolterodine—Dizziness—Thiotepa—sarcoma	0.00381	0.0052	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Epirubicin—sarcoma	0.00379	0.00518	CcSEcCtD
Tolterodine—Hypersensitivity—Vincristine—sarcoma	0.00377	0.00514	CcSEcCtD
Tolterodine—Weight increased—Epirubicin—sarcoma	0.00372	0.00507	CcSEcCtD
Tolterodine—Somnolence—Etoposide—sarcoma	0.00368	0.00503	CcSEcCtD
Tolterodine—Hypersensitivity—Mitoxantrone—sarcoma	0.00367	0.00501	CcSEcCtD
Tolterodine—Asthenia—Vincristine—sarcoma	0.00367	0.00501	CcSEcCtD
Tolterodine—Bronchitis—Doxorubicin—sarcoma	0.00363	0.00496	CcSEcCtD
Tolterodine—Headache—Thiotepa—sarcoma	0.00361	0.00493	CcSEcCtD
Tolterodine—Asthenia—Mitoxantrone—sarcoma	0.00357	0.00488	CcSEcCtD
Tolterodine—Fatigue—Etoposide—sarcoma	0.00357	0.00487	CcSEcCtD
Tolterodine—Pain—Etoposide—sarcoma	0.00354	0.00483	CcSEcCtD
Tolterodine—Constipation—Etoposide—sarcoma	0.00354	0.00483	CcSEcCtD
Tolterodine—Urinary tract infection—Epirubicin—sarcoma	0.00354	0.00483	CcSEcCtD
Tolterodine—Dysuria—Doxorubicin—sarcoma	0.00353	0.00482	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00351	0.00479	CcSEcCtD
Tolterodine—Diarrhoea—Vincristine—sarcoma	0.0035	0.00478	CcSEcCtD
Tolterodine—Weight increased—Doxorubicin—sarcoma	0.00344	0.00469	CcSEcCtD
Tolterodine—Sinusitis—Epirubicin—sarcoma	0.00342	0.00466	CcSEcCtD
Tolterodine—Feeling abnormal—Etoposide—sarcoma	0.00341	0.00466	CcSEcCtD
Tolterodine—Diarrhoea—Mitoxantrone—sarcoma	0.00341	0.00465	CcSEcCtD
Tolterodine—Gastrointestinal pain—Etoposide—sarcoma	0.00339	0.00462	CcSEcCtD
Tolterodine—Dizziness—Vincristine—sarcoma	0.00338	0.00462	CcSEcCtD
Tolterodine—Abdominal pain—Etoposide—sarcoma	0.00327	0.00447	CcSEcCtD
Tolterodine—Urinary tract infection—Doxorubicin—sarcoma	0.00327	0.00447	CcSEcCtD
Tolterodine—Oedema peripheral—Epirubicin—sarcoma	0.00322	0.00439	CcSEcCtD
Tolterodine—Headache—Vincristine—sarcoma	0.0032	0.00437	CcSEcCtD
Tolterodine—Sinusitis—Doxorubicin—sarcoma	0.00316	0.00431	CcSEcCtD
Tolterodine—Visual impairment—Epirubicin—sarcoma	0.00315	0.0043	CcSEcCtD
Tolterodine—Headache—Mitoxantrone—sarcoma	0.00312	0.00426	CcSEcCtD
Tolterodine—Hypersensitivity—Etoposide—sarcoma	0.00305	0.00417	CcSEcCtD
Tolterodine—Flushing—Epirubicin—sarcoma	0.00303	0.00414	CcSEcCtD
Tolterodine—Oedema peripheral—Doxorubicin—sarcoma	0.00298	0.00407	CcSEcCtD
Tolterodine—Asthenia—Etoposide—sarcoma	0.00297	0.00406	CcSEcCtD
Tolterodine—Visual impairment—Doxorubicin—sarcoma	0.00291	0.00398	CcSEcCtD
Tolterodine—Diarrhoea—Etoposide—sarcoma	0.00283	0.00387	CcSEcCtD
Tolterodine—Flushing—Doxorubicin—sarcoma	0.00281	0.00383	CcSEcCtD
Tolterodine—Flatulence—Epirubicin—sarcoma	0.0028	0.00383	CcSEcCtD
Tolterodine—Dizziness—Etoposide—sarcoma	0.00274	0.00374	CcSEcCtD
Tolterodine—Headache—Etoposide—sarcoma	0.00259	0.00354	CcSEcCtD
Tolterodine—Flatulence—Doxorubicin—sarcoma	0.00259	0.00354	CcSEcCtD
Tolterodine—Vertigo—Epirubicin—sarcoma	0.00256	0.00349	CcSEcCtD
Tolterodine—Palpitations—Epirubicin—sarcoma	0.00251	0.00343	CcSEcCtD
Tolterodine—Arthralgia—Epirubicin—sarcoma	0.00242	0.00331	CcSEcCtD
Tolterodine—Chest pain—Epirubicin—sarcoma	0.00242	0.00331	CcSEcCtD
Tolterodine—Anxiety—Epirubicin—sarcoma	0.00241	0.00329	CcSEcCtD
Tolterodine—Dry mouth—Epirubicin—sarcoma	0.00237	0.00323	CcSEcCtD
Tolterodine—Vertigo—Doxorubicin—sarcoma	0.00237	0.00323	CcSEcCtD
Tolterodine—Confusional state—Epirubicin—sarcoma	0.00234	0.0032	CcSEcCtD
Tolterodine—Palpitations—Doxorubicin—sarcoma	0.00233	0.00318	CcSEcCtD
Tolterodine—Anaphylactic shock—Epirubicin—sarcoma	0.00232	0.00317	CcSEcCtD
Tolterodine—Oedema—Epirubicin—sarcoma	0.00232	0.00317	CcSEcCtD
Tolterodine—Infection—Epirubicin—sarcoma	0.00231	0.00315	CcSEcCtD
Tolterodine—Tachycardia—Epirubicin—sarcoma	0.00227	0.00309	CcSEcCtD
Tolterodine—Arthralgia—Doxorubicin—sarcoma	0.00224	0.00306	CcSEcCtD
Tolterodine—Chest pain—Doxorubicin—sarcoma	0.00224	0.00306	CcSEcCtD
Tolterodine—Anxiety—Doxorubicin—sarcoma	0.00223	0.00305	CcSEcCtD
Tolterodine—Dry mouth—Doxorubicin—sarcoma	0.00219	0.00299	CcSEcCtD
Tolterodine—Confusional state—Doxorubicin—sarcoma	0.00217	0.00296	CcSEcCtD
Tolterodine—Anaphylactic shock—Doxorubicin—sarcoma	0.00215	0.00293	CcSEcCtD
Tolterodine—Oedema—Doxorubicin—sarcoma	0.00215	0.00293	CcSEcCtD
Tolterodine—Infection—Doxorubicin—sarcoma	0.00213	0.00291	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00212	0.00289	CcSEcCtD
Tolterodine—Tachycardia—Doxorubicin—sarcoma	0.0021	0.00286	CcSEcCtD
Tolterodine—Somnolence—Epirubicin—sarcoma	0.00206	0.00282	CcSEcCtD
Tolterodine—Dyspepsia—Epirubicin—sarcoma	0.00204	0.00279	CcSEcCtD
Tolterodine—Fatigue—Epirubicin—sarcoma	0.002	0.00273	CcSEcCtD
Tolterodine—Pain—Epirubicin—sarcoma	0.00199	0.00271	CcSEcCtD
Tolterodine—Constipation—Epirubicin—sarcoma	0.00199	0.00271	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00196	0.00267	CcSEcCtD
Tolterodine—Feeling abnormal—Epirubicin—sarcoma	0.00191	0.00261	CcSEcCtD
Tolterodine—Somnolence—Doxorubicin—sarcoma	0.00191	0.00261	CcSEcCtD
Tolterodine—Gastrointestinal pain—Epirubicin—sarcoma	0.0019	0.00259	CcSEcCtD
Tolterodine—Dyspepsia—Doxorubicin—sarcoma	0.00189	0.00258	CcSEcCtD
Tolterodine—Fatigue—Doxorubicin—sarcoma	0.00185	0.00253	CcSEcCtD
Tolterodine—Constipation—Doxorubicin—sarcoma	0.00184	0.00251	CcSEcCtD
Tolterodine—Pain—Doxorubicin—sarcoma	0.00184	0.00251	CcSEcCtD
Tolterodine—Abdominal pain—Epirubicin—sarcoma	0.00184	0.00251	CcSEcCtD
Tolterodine—Feeling abnormal—Doxorubicin—sarcoma	0.00177	0.00242	CcSEcCtD
Tolterodine—Gastrointestinal pain—Doxorubicin—sarcoma	0.00176	0.0024	CcSEcCtD
Tolterodine—Hypersensitivity—Epirubicin—sarcoma	0.00171	0.00233	CcSEcCtD
Tolterodine—Abdominal pain—Doxorubicin—sarcoma	0.0017	0.00232	CcSEcCtD
Tolterodine—Asthenia—Epirubicin—sarcoma	0.00167	0.00227	CcSEcCtD
Tolterodine—Diarrhoea—Epirubicin—sarcoma	0.00159	0.00217	CcSEcCtD
Tolterodine—Hypersensitivity—Doxorubicin—sarcoma	0.00158	0.00216	CcSEcCtD
Tolterodine—Asthenia—Doxorubicin—sarcoma	0.00154	0.0021	CcSEcCtD
Tolterodine—Dizziness—Epirubicin—sarcoma	0.00154	0.0021	CcSEcCtD
Tolterodine—Diarrhoea—Doxorubicin—sarcoma	0.00147	0.00201	CcSEcCtD
Tolterodine—Headache—Epirubicin—sarcoma	0.00145	0.00199	CcSEcCtD
Tolterodine—Dizziness—Doxorubicin—sarcoma	0.00142	0.00194	CcSEcCtD
Tolterodine—Headache—Doxorubicin—sarcoma	0.00135	0.00184	CcSEcCtD
